Changzhou Qianhong Bio-pharma
Changzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A pharma company focused on novel therapies for cardiovascular and metabolic disorders.
CardiovascularMetabolic
Technology Platform
A drug discovery platform focused on molecular targeting for cardiovascular and metabolic pathways, potentially incorporating formulation science for improved delivery.
Opportunities
Large and growing patient population in China for diabetes and heart disease creates a substantial addressable market for effective new therapies.
Risk Factors
High risk of clinical failure and significant challenges in achieving market differentiation against established, inexpensive generic treatments.
Competitive Landscape
Operates in a mature, highly competitive market dominated by global pharma giants and low-cost generic manufacturers, requiring truly innovative products to gain traction.